Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018801 (
heart failure
)
72,216
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The mineralocorticoid receptor (MR) is a member of the nuclear receptor superfamily. Pathological activation of the MR causes cardiac fibrosis and
heart failure
, but clinical use of MR antagonists is limited by the renal side effect of hyperkalemia. Coregulator proteins are known to be critical for nuclear receptor-mediated gene expression. Identification of coregulators, which mediate MR activity in a tissue-specific manner, may allow for the development of novel tissue-selective MR modulators that confer cardiac protection without adverse renal effects. Our earlier studies identified a consensus motif among MR-interacting peptides, MPxLxxLL. Gem (nuclear organelle)-associated protein 4 (
GEMIN4
) is one of the proteins that contain this motif. Transient transfection experiments in HEK293 and H9c2 cells demonstrated that
GEMIN4
repressed agonist-induced MR transactivation in a cell-specific manner. Furthermore, overexpression of
GEMIN4
significantly decreased, while knockdown of
GEMIN4
increased, the mRNA expression of specific endogenous MR target genes. A physical interaction between
GEMIN4
and MR is suggested by their nuclear co-localization upon agonist treatment. These findings indicate that
GEMIN4
functions as a novel coregulator of the MR.
...
PMID:GEMIN4 functions as a coregulator of the mineralocorticoid receptor. 2555 24